Results 281 to 290 of about 2,849,098 (354)

A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review. [PDF]

Cancer Med
Kotian N, Reddy Y, Pai P, Sundara BK.
europepmc   +1 more source

Treatment of Severe Ocular Mpox with Cidofovir and Tecovirimat. [PDF]

Emerg Infect Dis
Brousse X, Kreidie R, Mourgues E, Fraysse L, Lahouati M, Servant V, Burrel S, Saunier V, Cazanave C.   +8 more
europepmc   +1 more source

Risk Factors and Comparative Safety of Anti-PD-1 Combination Therapies in Advanced Melanoma: A Nationwide Real-World Cohort Study From China. [PDF]

Cancer Med
Qiao Y, Fu X, Shukar S, Ge W, Yang W, Jiang RB, Dai X, Chen H, Zhao J, Tang M, Mu F, Wang H, Wu Q, Xia X, Zhang Y, Ji S, Xu Y, Cao R, Wang J, Yao Y, Wang J, Fang Y.   +21 more
europepmc   +1 more source

Drug combinations in topical therapy.

The Western journal of medicine, 2010
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combination Drug Therapy

Journal of the American Medical Directors Association, 2005
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Eric G, Tangalos, Barbara J, Zarowitz
openaire   +2 more sources

Combination drug therapy via nanocarriers against infectious diseases.

European Journal of Pharmaceutical Sciences, 2019
Current drug therapy against infections is threatening to become obsolete due to the poor physical, chemical, biological and pharmacokinetic properties of drugs, followed by high risk of acquiring resistance.
P. Walvekar, Ramesh Gannimani, T. Govender   +2 more
semanticscholar   +1 more source

Combination drug therapy for dyslipidemia

Current Atherosclerosis Reports, 1999
Effective treatment of dyslipidemia improves prognosis. Statin therapy has been documented to decrease the cardiovascular event rate in the setting of elevated low-density lipoprotein (LDL) cholesterol levels and coronary heart disease, but most patients are not treated to the target (LDL
K, Alaswad, J H, O'Keefe, R M, Moe
openaire   +2 more sources

Combination Drug Therapy in Psychopharmacology

The Journal of Clinical Pharmacology, 1975
The frequency with which a psychotropic agent is used in combination with another drug preparation is emphasized. The authors present an update of the clinical and theoretical knowledge bearing on combination drug therapy in psychopharmacology. Drug combination interactions that enhance clinical efficacy and those that either diminish it or even ...
W E, Thornton, B J, Pray
openaire   +2 more sources

DDR drug combination therapy

2021
DDR drug combination therapy ...
Zhang, Hanrui, Yuanfang Guan
openaire   +1 more source

Combination Drug Therapy for Familial Combined Hyperlipidemia

Annals of Internal Medicine, 1988
To compare the efficacy of gemfibrozil and colestipol with gemfibrozil and lovastatin in patients with familial combined hyperlipidemia.A prospective, randomized trial.An outpatient clinical research center in a tertiary care center.Seventeen patients with familial combined hyperlipidemia documented by studies of first-degree relatives; nine patients ...
C, East, D W, Bilheimer, S M, Grundy
openaire   +2 more sources